For Patients With Inoperable Stage I NSCLC, Race, Hospital, and Insurance Status Matter
December 2nd 2014Despite the proven benefits of SBRT for patients with inoperable stage I NSCLC, whether such patients are offered it depends on their race, insurance status, and the type of facility where they are being treated.
Fewer Side Effects, Cost Savings, With Single-Fraction Radiotherapy for Bone Metastases
August 6th 2014A new study has found that standardizing prescribing practices for single-fraction radiation therapy (SFRT) for palliation of bone metastases may result in cost savings and an improvement in patients' quality of life.